Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HNSCC,Larynx, Pharynx and Oral Cavity”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Testing effectiveness (Phase 2)Looking for participantsNCT05136196
What this trial is testing

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more
National Cancer Institute (NCI) 150
Large-scale testing (Phase 3)Study completedNCT00004234
What this trial is testing

Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx

Who this might be right for
Head and Neck CancerOral Complications
NCIC Clinical Trials Group
Very early researchStudy completedNCT03238365
What this trial is testing

Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Lip, Oral Cavity and PharynxLarynx
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 50
Large-scale testing (Phase 3)Study completedNCT00162708
What this trial is testing

Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC

Who this might be right for
Oropharynx CancerOral CancerHypopharynx Cancer+1 more
Gustave Roussy, Cancer Campus, Grand Paris 120
Testing effectiveness (Phase 2)Study completedNCT00004901
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer

Who this might be right for
Head and Neck Cancer
Robert H. Lurie Cancer Center
Early research (Phase 1)Ended earlyNCT02205398
What this trial is testing

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Who this might be right for
Squamous Cell Carcinoma of Head and Neck (SCCHN)Metastatic Colorectal Cancer
Novartis Pharmaceuticals 13
Not applicableUnknownNCT00963326
What this trial is testing

Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 60
Not applicableStudy completedNCT00809016
What this trial is testing

PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 40
Not applicableUnknownNCT05992610
What this trial is testing

Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy

Who this might be right for
Squamous Cell Carcinoma of Oral CavityPharynx CarcinomaLarynx Carcinoma+1 more
Maria Sklodowska-Curie National Research Institute of Oncology 40
Large-scale testing (Phase 3)Study completedNCT00050388
What this trial is testing

Phase II Trial of Allovectin-7® for Head and Neck Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of the Oral Cavity or OropharynxHead and Neck Neoplasms+1 more
Vical
Early research (Phase 1)Study completedNCT00005647
What this trial is testing

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 12
Early research (Phase 1)Active Not RecruitingNCT04533750
What this trial is testing

Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Who this might be right for
Advanced Head and Neck Squamous Cell CarcinomaAdvanced Hypopharyngeal Squamous Cell CarcinomaAdvanced Laryngeal Squamous Cell Carcinoma+15 more
National Cancer Institute (NCI) 21
Early research (Phase 1)Looking for participantsNCT04754321
What this trial is testing

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Who this might be right for
Head and Neck Carcinoma of Unknown PrimaryLocally Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+3 more
Ohio State University Comprehensive Cancer Center 45
Large-scale testing (Phase 3)Active Not RecruitingNCT05721755
What this trial is testing

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+8 more
ECOG-ACRIN Cancer Research Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT05172258
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+12 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00833261
What this trial is testing

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Texas Southwestern Medical Center 37
Not applicableUnknownNCT03942380
What this trial is testing

Cell-free Tumor DNA in Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma+24 more
Christian von Buchwald 500
Large-scale testing (Phase 3)Active Not RecruitingNCT04590963
What this trial is testing

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 370
Early research (Phase 1)Looking for participantsNCT06868433
What this trial is testing

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
Emory University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03854032
What this trial is testing

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
LipOral Cavity Squamous Cell CarcinomaPharynx+2 more
Thomas Jefferson University 45
Load More Results
290
52
40